Results 21 to 30 of about 879,424 (313)
Epidemiology of venous thromboembolism in the Framingham Heart Study [PDF]
Reports of the crude incidence of venous thromboembolism (VTE) in Western countries vary widely. Data regarding risk factors, incidence and recurrence of VTE from deeply-phenotyped community-based cohort studies are needed.To study the incidence, associated mortality, and predisposing factors of VTE in the prospective, longitudinal community-based ...
Jared W. Magnani +6 more
openaire +2 more sources
Circulating ceramide ratios and risk of vascular brain aging and dementia
Background We determined the association between ratios of plasma ceramide species of differing fatty‐acyl chain lengths and incident dementia and Alzheimer’s disease (AD) dementia in a large, community‐based sample.
Emer R. McGrath +12 more
doaj +1 more source
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease
BackgroundPlasminogen activator inhibitor type 1 (PAI‐1) plays an essential role in the fibrinolysis system and thrombosis. Population studies have reported that blood PAI‐1 levels are associated with increased risk of coronary heart disease (CHD ...
Ci Song +4 more
doaj +1 more source
Consent for genetic research in the Framingham Heart Study [PDF]
AbstractExtensive efforts have been aimed at understanding the genetic underpinnings of complex diseases that affect humans. Numerous genome‐wide association studies have assessed the association of genes with human disease, including the Framingham Heart Study (FHS), which genotyped 550,000 SNPs in 9,000 participants.
Ralph B. D'Agostino +28 more
openaire +2 more sources
Circulating IGFBP‐2: a novel biomarker for incident dementia
Objective To determine the association between plasma insulin‐like growth factor binding protein 2 (IGFBP‐2) and cognitive outcomes. Methods We measured plasma IGFBP‐2 levels in 1596 (53% women, mean age 68.7 [SD 5.7] years) dementia‐free Framingham ...
Emer R. McGrath +10 more
doaj +1 more source
Arterial Stiffness and Diabetes Risk in Framingham Heart Study and UK Biobank
Background: Microvascular damage from large artery stiffness (LAS) in pancreatic, hepatic, and skeletal muscles may affect glucose homeostasis. Our goal was to evaluate the association between LAS and the risk of type 2 diabetes using prospectively ...
Jordana B. Cohen +9 more
semanticscholar +1 more source
Contemporary Trends in Dyslipidemia in the Framingham Heart Study [PDF]
Recent cross-sectional population studies in the United States have shown an increase in obesity, a decrease in cholesterol values, but no changes in levels of high-density lipoprotein cholesterol (HDL-C) or triglycerides (TG).Plasma total cholesterol, HDL-C, and TG levels, measured by the same methods at the 3 most recently completed examinations of ...
Joseph M. Massaro +7 more
openaire +3 more sources
Aims. Circulating insulin-like growth factor- (IGF-) 1, vascular endothelial growth factor (VEGF), and brain-derived neurotrophic factor (BDNF) levels are often lower in individuals with diabetes mellitus (DM) and are important for repairing vascular and
Nicole L. Spartano +6 more
doaj +1 more source
Arterial Stiffness and Long-Term Risk of Health Outcomes: The Framingham Heart Study
Background: Arterial stiffness increases with age and is associated with an increased risk of adverse outcomes on short-term follow-up (typically
R. Vasan +6 more
semanticscholar +1 more source
Abstract Hypertension guidelines recommend measuring blood pressure (BP) in both arms at least once. However, this is seldom done due to uncertainties regarding measurement procedure and the implications of finding a clinically important inter‐arm BP difference (IAD).
Gurpreet S. Wander +19 more
wiley +1 more source

